- Home
- CFG vs NTRA Comparison
CFG vs NTRA Comparison
Compare CFG & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFG
- NTRA
- Stock Information
- Founded
- CFG 1828
- NTRA 2003
- Country
- CFG United States
- NTRA United States
- Employees
- CFG N/A
- NTRA N/A
- Industry
- CFG Major Banks
- NTRA Medical Specialities
- Sector
- CFG Finance
- NTRA Health Care
- Exchange
- CFG Nasdaq
- NTRA Nasdaq
- Market Cap
- CFG 21.3B
- NTRA 20.9B
- IPO Year
- CFG 2014
- NTRA 2015
- Fundamental
- Price
- CFG $39.11
- NTRA $151.95
- Analyst Decision
- CFG Buy
- NTRA Strong Buy
- Analyst Count
- CFG 17
- NTRA 17
- Target Price
- CFG $47.41
- NTRA $178.41
- AVG Volume (30 Days)
- CFG 4.9M
- NTRA 1.1M
- Earning Date
- CFG 04-16-2025
- NTRA 05-08-2025
- Dividend Yield
- CFG 4.30%
- NTRA N/A
- EPS Growth
- CFG 13.68
- NTRA N/A
- EPS
- CFG 3.15
- NTRA N/A
- Revenue
- CFG $7,116,000,000.00
- NTRA $1,831,000,000.00
- Revenue This Year
- CFG $15.57
- NTRA $15.45
- Revenue Next Year
- CFG $8.30
- NTRA $18.43
- P/E Ratio
- CFG $12.39
- NTRA N/A
- Revenue Growth
- CFG N/A
- NTRA 51.50
- 52 Week Low
- CFG $32.60
- NTRA $92.14
- 52 Week High
- CFG $49.25
- NTRA $183.00
- Technical
- Relative Strength Index (RSI)
- CFG 56.27
- NTRA 49.96
- Support Level
- CFG $37.93
- NTRA $153.40
- Resistance Level
- CFG $39.36
- NTRA $159.15
- Average True Range (ATR)
- CFG 0.94
- NTRA 6.36
- MACD
- CFG 0.47
- NTRA 0.65
- Stochastic Oscillator
- CFG 94.48
- NTRA 39.44
About CFG Citizens Financial Group Inc.
Citizens Financial Group is a bank holding company headquartered in Providence, Rhode Island. Its two primary business segments are consumer banking and commercial banking. Citizens offers a mix of retail and commercial products including capital markets and wealth options. The bank has over 1,100 branches in 14 states, although it is concentrated in the Northeast. It has over $220 billion of total assets. It generates maximum revenue from Consumer Banking Segment.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.